Showing results (471-480 of 598) with videos related to

Sort By:
Pageof 60
Plos One|May 27, 2021
Perspectives of nurses' role in interprofessional pharmaceutical care across 14 European countries: A qualitative study in pharmacists, physicians and nursesElyne De Baetselier, Tinne Dilles, Luis M Batalha, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life studyC Patruno, M Napolitano, G Argenziano, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
BMJ Open|June 6, 2020
EUPRON: nurses' practice in interprofessional pharmaceutical care in Europe. A cross-sectional survey in 17 countriesElyne De Baetselier, Bart Van Rompaey, Luis M Batalha, et al.
Dermatology Reports|October 6, 2022
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore ProjectFrancesco Cusano, Francesca Sampogna, Alexandra Maria Giovanna Brunasso Vernetti, et al.
Dermatology (Basel, Switzerland)|July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert PanelAnnamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
The Journal of Dermatological Treatment|October 25, 2019
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitisM C Fargnoli, M Esposito, S Ferrucci, et al.
NPJ Precision Oncology|November 28, 2018
Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumourN Malara, F Gentile, N Coppedè, et al.
Paediatric Drugs|August 26, 2022
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life StudyMaddalena Napolitano, Gabriella Fabbrocini, Iria Neri, et al.
Pageof 60